CYDY (CytoDyn) Research & Development: $14.41 Mil (TTM As of Feb. 2026)


CYDY CytoDyn Inc CYDY
28 GF Score
Price $0.25
! 1 Warning Sign
View Full Analysis

What is CytoDyn Research & Development?

CytoDyn CYDY -0.48% 28 Research & Development is $14.41 Mil as of Feb. 2026. GuruFocus rates CYDY with a GF Score™ of 28/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CytoDyn's Research & Development for the three months ended in Feb. 2026 was $4.65 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was $14.41 Mil.

CytoDyn  (OTCPK:CYDY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CytoDyn Research & Development Related Terms

CytoDyn Research & Development Historical Data

* Premium members only.

The historical data trend for CytoDyn's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CytoDyn Research & Development Chart

CytoDyn Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.40 27.04 2.63 7.24 -16.92

CytoDyn Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.49 3.23 3.23 3.30 4.65
CYDY
28GF Score
CytoDyn Inc CYDY
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CytoDyn Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $14.41 Mil mean?
CytoDyn (CYDY) has a Research & Development of $14.41 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on CytoDyn and its competitors.
Is CytoDyn's Research & Development too high?
CytoDyn's current Research & Development is $14.41 Mil. Overall, CytoDyn has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does CytoDyn's Research & Development compare to ZURA and XFOR?
CytoDyn's Research & Development of $14.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CytoDyn and its competitors. CytoDyn's current Research & Development is $14.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CytoDyn stock overvalued right now?
CytoDyn (CYDY) has a current Research & Development of $14.41 Mil. The current Research & Development is $14.41 Mil. CytoDyn's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CytoDyn (CYDY), the current Research & Development is $14.41 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CytoDyn Business Description

Other Exchanges 296:Germany
Address 1111 Main Street, Suite 660, Vancouver, WA, USA, 98660
CytoDyn Inc is a USA-based clinical-stage biotechnology company that focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The product candidate is PRO 140, which is a class of HIV therapy called entry inhibitors that block HIV from entering into and infecting certain cells. The company emphasizes exploring opportunities for clinical applications for PRO 140 involving the CCR5 (C-C chemokine receptor type 5) receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases, and cancer.
28GF Score

Get the complete analysis for CYDY

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price